Xcout Intel
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER) antagonist and selective ER degrader, is presently undergoing Phase 1/2 clinical evaluations. This drug candidate is being assessed for its efficacy in managing recurrent, locally advanced, or metastatic breast cancer that expresses estrogen receptors but is negative for human epidermal growth factor receptor 2.
Subscribe to see Olema Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Olema Pharmaceuticals, Inc. at a glance
Olema Pharmaceuticals, Inc. is a biotechnology company headquartered in San Francisco, United States. It is publicly listed (OLMA) with a market capitalisation of $693.5M. Xcout tracks 73 named people at Olema Pharmaceuticals, Inc., including Sean Bohen (President, Chief Executive Officer & Director). Xcout recorded 39 job postings from Olema Pharmaceuticals, Inc. in the last 90 days.
Olema Pharmaceuticals, Inc. leadership
- Sean BohenPresident, Chief Executive Officer & Director
- Sean P. Bohen, M.D., Ph.D.President and CEO
- Jason O'ByrneCFO, Principal Financial Officer & Accounting Officer
- Naseem ZojwallaChief Medical Officer
- Shawnte MitchellChief Legal Officer & Corporate Secretary
- David C. MylesChief Scientific Officer
67 more named people on record for Olema Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →
Olema Pharmaceuticals, Inc. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $87.4M | 8 named |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Olema Pharmaceuticals, Inc.
Xcout recorded 39 job postings from Olema Pharmaceuticals, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Olema Pharmaceuticals, Inc.'s hiring signals →
Investors
Get Olema Pharmaceuticals, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Olema Pharmaceuticals, Inc. in Xcout Intel
- 73 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access